基本信息
views: 10
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Hostetler is the co-inventor of Antiva Biosciences’ intellectual property with two UCSD scientists. Dr. Hostetler was previously a founder and served on the Boards of Directors of three biopharmaceutical companies: Vical, Inc. (VICL), Triangle Pharmaceuticals (VIRS, acquired by Gilead Sciences), and Chimerix Inc. (CMRX). He retired from Chimerix in 2012 to found Hera Therapeutics, Inc., now Antiva Biosciences, Inc. In 2012 Dr. Hostetler was the recipient of the Gertrude Elion Memorial Award from the International Society for Antiviral Research for his work in antiviral drug design. He has authored or co- authored over 200 scientific publications and is an inventor on 66 issued US Patents. Dr. Hostetler holds an M.D. degree from Western Reserve University and is currently an Active Emeritus Professor of Medicine in the Division of Infectious Disease at UCSD.
Research Interests
Papers共 254 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Antiviral research (2023): 105718-105718
Journal of medicinal chemistryno. 8 (2023): 5802-5819
Robert T Schooley,Aaron F Carlin,James R Beadle,Nadejda Valiaeva,Xing-Quan Zhang,Alex E Clark,Rachel E McMillan,Sandra L Leibel, Rachael N McVicar,Jialei Xie, Aaron F Garretson,Victoria I Smith,
bioRxiv : the preprint server for biologypp.1-21, (2021)
Microbiology spectrumno. 3 (2021): e0153721-e0153721
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn